Related Experiment Video
Updated: Jun 4, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Adrenal suppression following intralesional corticosteroids for periocular haemangiomas
C Morkane1, J W Gregory, P Watts
1University Hospital of Wales, Heath Park, Cardiff, UK.
Insights
Intralesional corticosteroid injections for infantile periocular haemangiomas commonly cause prolonged adrenal suppression and weight gain issues. Recovery of normal adrenal function is linked to improved weight gain in infants.
Area of Science:
- Pediatric Endocrinology
- Ophthalmology
- Dermatology
Background:
- Intralesional triamcinolone/betamethasone is a recommended treatment for infantile sight-threatening periocular haemangiomas.
- The endocrine and weight effects of this therapy in infants are not well-documented.
Purpose of the Study:
- To investigate endocrine changes, specifically serum cortisol and ACTH levels.
- To assess weight changes in infants treated with intralesional triamcinolone/betamethasone for periocular haemangiomas.
Main Methods:
- 15 infants with periocular haemangiomas received intra/perilesional triamcinolone/betamethasone.
- Serial measurements of weight, serum cortisol, and ACTH were taken before and after treatment.
Main Results:
- Significant reductions in cortisol and ACTH levels were observed 4 weeks post-injection.
- 13 out of 15 infants experienced prolonged adrenal suppression, with recovery taking a median of 19.5 weeks.
- 14 infants showed faltering weight gain, which resolved with the re-establishment of normal adrenal function.
Conclusions:
- Intralesional corticosteroid injections for periocular haemangiomas frequently lead to prolonged adrenal suppression.
- This endocrine disruption is associated with impaired weight gain in infants.
Background/Aims:
Treatment with intralesional triamcinolone/betamethasone is recommended for infantile sight-threatening periocular haemangiomas. This study investigates the endocrine and weight changes in 15 infants undergoing therapy over 12 years.
Methods:
15 infants, median age 19 weeks (range 10-56) receiving intra/perilesional triamcinolone/betamethasone underwent serial measurement of weight, early morning serum cortisol and adrenocorticotropic hormone (ACTH) before and after injection.
Results:
Cortisol fell from a median (range) of 383 (112-594) to 28 (<10-506) nmol/l (p=0.005) and ACTH from 26 (14-134) to 9 (5-20) ng/l (p=0.05) from before injection to 4 weeks after treatment. Prolonged adrenal suppression occurred in 13 out of 15 cases with time to recovery being 19.5 (4-65) weeks. Failure to gain weight appropriately was observed in 14 infants but recovered once normal adrenal function was re-established.
Conclusion:
Prolonged adrenal suppression following triamcinolone/betamethasone injection for periocular haemangiomas is common and associated with faltering weight gain.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome II: Pathophysiology